1.Pollution characteristics, source apportionment, and health risk assessment of PM2.5-bound polycyclic aromatic hydrocarbons in Guangzhou City from 2016 to 2024
Yan WU ; Zhi LI ; Jiayun LYU ; Jie SHI ; Yongquan PENG ; Wenru FENG
Journal of Environmental and Occupational Medicine 2026;43(9):1116-1122
Background Polycyclic aromatic hydrocarbons (PAHs) are significant organic components of PM2.5 and exhibit carcinogenic and mutagenic properties. Long-term exposure to high level of atmospheric particulate matter and particle-bound PAHs may contribute to the burden of environmentally related diseases in China. Objective To characterize PM2.5 concentrations and PM2.5-bound PAHs in three districts of Guangzhou from 2016 to 2024, and to assess the incremental lifetime cancer risk (ILCR) associated with inhalation exposure to PAHs among different population groups. Methods PM2.5 samples were collected monthly from the 10th to the 16th day of each month at rooftop monitoring sites on office buildings in Yuexiu, Conghua, and Panyu districts between 2016 and 2024. PM2.5 concentrations were measured, and 16 priority PAHs were quantified using high-performance liquid chromatography (HPLC). Seasonal and regional variations in PM2.5 and PAH concentrations were analyzed using the Kruskal-Wallis test. Potential PAH sources were identified using diagnostic ratio analysis and principal component analysis (PCA). The ILCR model was employed to estimate inhalation-related cancer risks for different population groups. Results From 2016 to 2024, the annual median PM2.5 concentrations in Guangzhou were 51.0, 46.0, 45.0, 41.5, 31.0, 32.0, 30.0, 26.0, and 37.5 μg·m−3, respectively, showing an overall declining trend. PM2.5 concentrations varied significantly by season, following the order of winter > spring/autumn > summer (H=475.341, P < 0.001). Spatially, PM2.5 concentrations were highest in Yuexiu, followed by Panyu and Conghua (H=36.226, P < 0.001). The annual median PAH concentrations were 3.95, 4.22, 3.73, 3.13, 2.54, 2.16, 2.78, 2.36, and 1.75 ng·m−3, respectively. PAH concentrations showed a similar seasonal pattern (winter > spring/autumn > summer; H=320.392, P < 0.001). However, their spatial distribution differed from that of PM2.5: Conghua > Panyu > Yuexiu (H=55.938, P < 0.001). Diagnostic ratios and PCA indicated that the major sources of PAHs were traffic-related emissions (gasoline and diesel combustion) and coal combustion, with additional contributions from petroleum volatilization and biomass burning. Benzo[a]pyrene (BaP) toxic equivalent concentrations declined over time and remained below the Chinese standard limit of 1 ng·m−3 after 2018. The median inhalation-related ILCRs were 0.094×10−6 for children, 0.035×10−6 for adolescents, and 0.293×10−6 for adults. Conclusion From 2016 to 2024, PM2.5 and PM2.5-bound PAH pollution levels in Guangzhou generally declined. Suburban areas had the lowest PM2.5 concentrations but the highest PAHs concentrations. Both PM2.5 and PM2.5-bound PAHs exhibited significant seasonal variations, with the highest levels in winter and the lowest levels in summer. The primary sources of PAHs were vehicular emissions and coal combustion, and PAHs posed no significant carcinogenic risk to the study population.
2.Exploration and practice of medical laboratory health economics
Jingfei LYU ; Jiayun LIU ; Haiyin WANG ; Xiaobing XIE ; Jiancheng XU ; Bing GU ; Yingchun XU
Chinese Journal of Laboratory Medicine 2025;48(4):453-458
The reliability and practicality of research findings in health economics are gradually becoming core issues of close concern for clinical and public health experts. As healthcare resources remain under increasing pressure, conducting efficient cost-effectiveness analyses and achieving rational resource allocation are becoming ever more critical. In recent years, medical laboratory health economics has transitioned from purely academic discussions to integration into clinical practice, becoming a key tool for improving the efficiency and quality of healthcare services. It has demonstrated remarkable results in optimizing patient management and medical decision-making processes. So we invited experts from the fields of medical laboratory science and health economics to share valuable experiences and unique insights on topics such as cost assessment methods, pricing strategies, quality regulation, and the role of medical laboratory health economics in enhancing clinical practice and patient benefits. These experts generally agree that, while research in medical laboratory health economics has shown significant advantages and effectively addressed urgent clinical needs in resource allocation and cost control, it still faces multiple challenges, including limitations in research methodology application, high operational costs, and insufficient standardization of management systems.
3.Exploration and practice of medical laboratory health economics
Jingfei LYU ; Jiayun LIU ; Haiyin WANG ; Xiaobing XIE ; Jiancheng XU ; Bing GU ; Yingchun XU
Chinese Journal of Laboratory Medicine 2025;48(4):453-458
The reliability and practicality of research findings in health economics are gradually becoming core issues of close concern for clinical and public health experts. As healthcare resources remain under increasing pressure, conducting efficient cost-effectiveness analyses and achieving rational resource allocation are becoming ever more critical. In recent years, medical laboratory health economics has transitioned from purely academic discussions to integration into clinical practice, becoming a key tool for improving the efficiency and quality of healthcare services. It has demonstrated remarkable results in optimizing patient management and medical decision-making processes. So we invited experts from the fields of medical laboratory science and health economics to share valuable experiences and unique insights on topics such as cost assessment methods, pricing strategies, quality regulation, and the role of medical laboratory health economics in enhancing clinical practice and patient benefits. These experts generally agree that, while research in medical laboratory health economics has shown significant advantages and effectively addressed urgent clinical needs in resource allocation and cost control, it still faces multiple challenges, including limitations in research methodology application, high operational costs, and insufficient standardization of management systems.
4.A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers
Yuqing MENG ; Jiayun CHEN ; Yanqing LIU ; Yongping ZHU ; Yin-Kwan WONG ; Haining LYU ; Qiaoli SHI ; Fei XIA ; Liwei GU ; Xinwei ZHANG ; Peng GAO ; Huan TANG ; Qiuyan GUO ; Chong QIU ; Chengchao XU ; Xiao HE ; Junzhe ZHANG ; Jigang WANG
Journal of Pharmaceutical Analysis 2022;12(6):879-888
The composition of serum is extremely complex,which complicates the discovery of new pharmaco-dynamic biomarkers via serum proteome for disease prediction and diagnosis.Recently,nanoparticles have been reported to efficiently reduce the proportion of high-abundance proteins and enrich low-abundance proteins in serum.Here,we synthesized a silica-coated iron oxide nanoparticle and devel-oped a highly efficient and reproducible protein corona(PC)-based proteomic analysis strategy to improve the range of serum proteomic analysis.We identified 1,070 proteins with a median coefficient of variation of 12.56%using PC-based proteomic analysis,which was twice the number of proteins iden-tified by direct digestion.There were also more biological processes enriched with these proteins.We applied this strategy to identify more pharmacodynamic biomarkers on collagen-induced arthritis(CIA)rat model treated with methotrexate(MTX).The bioinformatic results indicated that 485 differentially expressed proteins(DEPs)were found in CIA rats,of which 323 DEPs recovered to near normal levels after treatment with MTX.This strategy can not only help enhance our understanding of the mechanisms of disease and drug action through serum proteomics studies,but also provide more pharmacodynamic biomarkers for disease prediction,diagnosis,and treatment.
5.Complications of hypertension in Minhang District of Shanghai based on electronic health records
Jiayun WANG ; Jun LI ; Tongtong LIANG ; Guo XUAN ; Pu LIU ; Jinling ZHANG ; Yuhong AO ; Jun LYU ; Chengyue LI
Shanghai Journal of Preventive Medicine 2022;34(9):895-900
ObjectiveTo determine the complications of hypertension among local residents in Minhang district of Shanghai, and provide scientific evidence for key preventive intervention. MethodsWe retrieved the data from the electronic health records, in which hypertensive patients were included for community-based management, in Minhang district of Shanghai from January 1st, 2014 to December 31st, 2018. A total of 38 599 hypertensive patients who had not had hypertension related clinical symptom when included in the electronic health records were enrolled in our study. Chi-square test and Cochran-Mantel-Haenszel test were used to determine the complications of hypertension. ResultsThe incidence proportion of complications was 10.77%, of which cerebrovascular damage was the highest (7.44%), followed by cardiac damage (3.55%) and peripheral vascular damage (0.81%). The incidence proportions in patients aged 18‒59, 60‒69, 70 and above were 5.53%, 9.61% and 16.19%, respectively. There was significant difference in the incidence proportions of complications among age groups (χ²=668.670, P<0.05). Cochran-Mantel-Haenszel test showed that in the hypertensive patients aged 60‒69, the incidence proportion of complications in females was lower than that in males (χ²=5.937, P<0.05). However, in those aged above 70, the incidence proportion of complications in females was higher than that in males (χ²=11.619, P<0.05). ConclusionIn patients with hypertension, the incidence proportions of cardiovascular and cerebrovascular diseases remains relatively high in Minhang district of Shanghai. Additionally, both age and gender have influence on the incidence of complications.
6.Investigative analysis of the different pychological demands of caregivers in different relation of severe craniocerebral trauma patients
Yongfang ZHANG ; Jiayun LU ; Jinjin GE ; Weibo LYU
Chinese Journal of Modern Nursing 2015;21(5):516-518
Objective To investigate the psychological demands of caregivers who take care of severe craniocerebral trauma patients, and to analyze different psychological needs of caregivers in different relation, such as parents, spouses, children, brothers and sisters. Methods We used the Critical Care Family Needs Inventory to investigate 391 relatives of patients in neurosurgical intensive care unit in four hospitals by stratified sampling, in order to understand the psychological demands of people who take care of severe craniocerebral trauma patients. Results The total demand score of 391 caregivers was (136. 63 ± 18. 56),which was at the moderate level. There was significant different demand of different relative caregivers in information factor, proximity factor and assurance factor (F=5. 103, 5. 032, 7. 811, respectively;P<0. 01). Conclusions The psychological demands of caregivers who take care of severe craniocerebral trauma patients had relative high psychological needs. The clinic staffs should pay attention to the difference of demand, and give them psychological care to reduce their psychological stress and prevent mental problems.

Result Analysis
Print
Save
E-mail